본문 바로가기

연구소

연구논문 및 특허성과

  • Home
  • 연구소
  • 연구논문 및 특허성과

논문성과

암센터 국문 논문 목록
학술지 책임저자
제1저자
저자,논문명,학술지명,발간일;년도;페이지:통권(Impact Factor)
The efficacy of slow-rate ventriculolumbar perfusion chemotherapy for leptomeningeal carcinomatosis: a phase II study 곽호신
(암관리학과)
곽호신:Soojin Jang:도윤식, 신상훈, 유헌, 왕규창 외. The efficacy of slow-rate ventriculolumbar perfusion chemotherapy for leptomeningeal carcinomatosis: a phase II study ACTA NEUROCHIRURGICA. 2024-03-01; 2024; 166(1):117~. IF 2.4 (2022)
Soojin Jang
Differential response to roflumilast in patients with chronicobstructive pulmonary disease: real-world evidence Deog Kyeom Kim
Deog Kyeom Kim:선지유, Hyun Woo Lee:. Differential response to roflumilast in patients with chronicobstructive pulmonary disease: real-world evidence JOURNAL OF THORACIC DISEASE. 2024-02-27; 2024; 16(2):1338~1349. IF 2.5 (2022)
선지유
(융합바이오통계연구과)
Cancer risk according to fasting blood glucose trajectories: A population-based cohort study 오진경
(임상간호학과)
오진경:Thi Minh Thu Khong:Thi Tra Bui, 강희연, 이진희, 박은정. Cancer risk according to fasting blood glucose trajectories: A population-based cohort study BMJ OPEN DIABETES RESEARCH & CARE. 2024-02-27; 2024; 12(1):e003696~. IF 4.1 (2022)
Thu Thi Minh KHONG
(암의생명과학과)
Factors related to tumor response rate from TCGA three omics data-variants, expression, methylation Jeong-An Gim
Jeong-An Gim:안형민, Insu Park:Chang Geun Kim, Young Kyung Ko. Factors related to tumor response rate from TCGA three omics data-variants, expression, methylation JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-TOXICOLOGY AND CARCINOGENESIS. 2024-02-26; 2024; :~. IF 2.5 (2022)
안형민
(폐암센터)
Correspondence on Editorial regarding 이연수
(희귀ㆍ소아암연구과)
이연수, Kyung Hyun Yoo, Jong Hoon Park:Sungju Jung, Sumin Yoon:. Correspondence on Editorial regarding "Identification of signature gene set as highly accurate determination of MASLD progression" CLINICAL AND MOLECULAR HEPATOLOGY. 2024-02-23; 2024; 30(2):287~290. IF 8.9 (2022)
Sungju Jung, Sumin Yoon
Factors affecting accuracy of clinical staging in resectable non-smal cell lung cancer in a real-world study Seong Yong Park, Sang Hoon Lee
Seong Yong Park, Sang Hoon Lee:권혜란:. Factors affecting accuracy of clinical staging in resectable non-smal cell lung cancer in a real-world study THORACIC CANCER. 2024-02-21; 2024; 15(9):730~737. IF 2.9 (2022)
권혜란
(호흡기내과분과)
Integrative transcriptomic and genomic analyses unveil the IFI16 variants and expression as a MASLD progression markers 이연수
(희귀ㆍ소아암연구과)
이연수, Hyun Goo Woo:Doyoon Kim, Masaud Shah:이용선, 박가을 외. Integrative transcriptomic and genomic analyses unveil the IFI16 variants and expression as a MASLD progression markers HEPATOLOGY. 2024-02-20; 2024; :~. IF 14 (2022)
이연수
(희귀ㆍ소아암연구과)
Disseminating Necrotizing Leukoencephalopathy Associated With Intra-CSF Methotrexate Chemotherapy: A Retrospective Observational Study 곽호신
(신경외과)
곽호신:김기훈, Moowan Park:박은영, 김수현, 서지원, 현재원, 김호진, 도윤식, 신상훈, 유헌, 왕규창. Disseminating Necrotizing Leukoencephalopathy Associated With Intra-CSF Methotrexate Chemotherapy: A Retrospective Observational Study NEUROLOGY. 2024-02-16; 2024; 102(5):e209167~. IF 10.1 (2022)
김기훈
(신경과)
The online promotion strategies of e-cigarette and heated tobacco product retailers in South Korea following the COVID-19 pandemic: Implications for regulation 강은교
(암검진사업부)
강은교:HyoRim Ju:이혜원, 최주영, Soojeong Kim. The online promotion strategies of e-cigarette and heated tobacco product retailers in South Korea following the COVID-19 pandemic: Implications for regulation TOBACCO INDUCED DISEASES. 2024-02-14; 2024; :~. IF 3.7 (2022)
HyoRim Ju
Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy 한지연1
(치료내성연구과)
한지연:김선신, 이영주:송보람, 심한나, 강은혜, 황미화, 유남희, 홍세화, 박찬이, 안병철, 임은진, 황금희, 박석연, 최진호, 이건국. Drug Response of Patient-Derived Lung Cancer Cells Predicts Clinical Outcomes of Targeted Therapy CANCERS. 2024-02-14; 2024; 16(4):778~. IF 5.2 (2022)
김선신
(표적치료연구과)
이영주
(표적치료연구과)